Growth Metrics

Chemours (CC) Current Deferred Revenue (2016 - 2021)

Chemours has reported Current Deferred Revenue over the past 7 years, most recently at $3.0 million for Q4 2021.

  • Quarterly results put Current Deferred Revenue at $3.0 million for Q4 2021, down 57.14% from a year ago — trailing twelve months through Dec 2021 was $3.0 million (down 57.14% YoY), and the annual figure for FY2021 was $3.0 million, down 57.14%.
  • Current Deferred Revenue for Q4 2021 was $3.0 million at Chemours, up from $2.0 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for CC hit a ceiling of $23.0 million in Q1 2017 and a floor of $2.0 million in Q3 2021.
  • Median Current Deferred Revenue over the past 5 years was $7.0 million (2019), compared with a mean of $7.3 million.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 89.47% in 2017 and later skyrocketed 60.0% in 2019.
  • Chemours' Current Deferred Revenue stood at $8.0 million in 2017, then fell by 25.0% to $6.0 million in 2018, then increased by 16.67% to $7.0 million in 2019, then changed by 0.0% to $7.0 million in 2020, then plummeted by 57.14% to $3.0 million in 2021.
  • The last three reported values for Current Deferred Revenue were $3.0 million (Q4 2021), $2.0 million (Q3 2021), and $3.0 million (Q2 2021) per Business Quant data.